ArticleBritish journal of pharmacology2016

Pharmacological characterization of the first in class clinical candidate PF-05190457: a selective ghrelin receptor competitive antagonist with inverse agonism that increases vagal afferent firing and glucose-dependent insulin secretion ex vivo.

J Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.